Skip to content
Screener

Intellia Therapeutics NTLA Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$231.56M+41.3%
ALN
Alnylam PharmaceuticalsALNY
$183.36M-4.7%
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
$128.67M-8.3%
Beam Therapeutics logo
Beam TherapeuticsBEAM
$98.15M-4.0%
Design Therapeutics, Inc. logo
Design Therapeutics, Inc.DSGN
$2.57M+26.7%
Prime Medicine logo
Prime MedicinePRME
$120.47M+0.2%

Other financials

Income statement

See full
Revenue$7.7M-46.2%
Operating income-$112.8M-2.5%
Net income-$106.6M-5.3%
EPS (diluted)-$0.80+18.4%

Balance sheet

See full
Cash & equivalents$106.1M-32.0%
Total debt$73.4M-28.4%
Total equity$727.7M+202%
Total assets$857.2M-4.6%

Cash flow

See full
Operating cash flow-$83.1M+16.6%
CapEx$1.8M+657%
Free cash flow-$84.9M+15.0%

Valuation

See full
Market cap$1.68B+45.7%
Enterprise value$1.65B+49.8%
P/S28.2×+6.4×

Profitability

See full
Operating margin-711.7%-149pp
Net margin-672.2%-139pp
FCF margin-586%-123pp

Returns & leverage

See full
Return on equity-56.3%-1.5pp
Debt / equity0.1×
Current ratio6.6×+1.5×

Where this comes from

Reported directly by Intellia Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The source filing: Intellia Therapeutics’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:05 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-337952
Line itemJune 30,2026December 31,2025
Total current assets527,832527,711
Marketable securities - noncurrent190,595155,250
Property and equipment, net15,05817,671
Operating lease right-of-use assets85,954105,955
Investments and other assets37,72535,540
Total assets$857,164$842,127
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:

Item 1. Financial Statements

FAQ

What is Intellia Therapeutics's operating lease ROU assets?
Intellia Therapeutics (NTLA) reported operating lease ROU assets of $85.95M in Q2 2026.
How has Intellia Therapeutics's operating lease ROU assets changed year-over-year?
Intellia Therapeutics's operating lease ROU assets decreased by 33.4% year-over-year, from $129.05M to $85.95M.
What is the long-term trend for Intellia Therapeutics's operating lease ROU assets?
Over 5 years (2020 to 2025), Intellia Therapeutics's operating lease ROU assets has grown at a 22.1% compound annual growth rate (CAGR), from $39.11M to $105.96M.
What does operating lease ROU assets mean?
Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.

Ask your AI about Intellia Therapeutics's operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude